Posted Nov. 2, 2012 at 6:06 a.m.

Premium Lock GSK strikes deal to test combo of hepatitis C drugs

Published: 2012-11-02 06:06:00
Updated: 2012-11-02 06:06:00

Duke links genetics to hepatitis C treatment effectiveness Duke links genetics to hepatitis C treatment effectiveness Image 1 of 3 · Next Image…

Vertex Pharmaceuticals Inc., maker of the hepatitis C drug Incivek, said it agreed to test one of its experimental therapies for the disease with other drugs from Johnson & Johnson and GlaxoSmithKline....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2014 Bloomberg. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Vivek Wadhwa
Commentary
Dr. Mike Walden
Tech economy
Frank Vinluan
Life science
Scroll